| Symbol: |
ECT2L
|
| Description: |
epithelial cell transforming sequence 2 oncogene-like [Source:HGNC Symbol;Acc:21118]
|
| Location: |
Chr6:139117063-139225207[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:437
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| ECT2L |
NSC 682918 |
0.019 |
Down |
| ECT2L |
NSC 684807 |
0.013 |
Down |
| ECT2L |
Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- |
0.027 |
Down |
| ECT2L |
2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 |
0.029 |
Down |
| ECT2L |
NSC 684971 |
0.001 |
Down |
| ECT2L |
NSC 684987 |
0.034 |
Up |
| ECT2L |
Dipyrazolo[3,4-f:3',4'-g]-2-pyrindine-3,4(2H,5H)-dione, 2,5-diphenyl- |
0.039 |
Down |
| ECT2L |
NSC 685849 |
0.011 |
Down |
| ECT2L |
NSC 686138 |
0.006 |
Down |
| ECT2L |
NSC 686505 |
0.032 |
Down |
| ECT2L |
NSC 687526 |
0.036 |
Down |
| ECT2L |
Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (5-nitro-2-thienyl)methyl ester |
0.018 |
Down |
| ECT2L |
Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (1,4-dioxo-2-naphthalenyl)methyl ester |
0.025 |
Down |
| ECT2L |
NSC 688526 |
0.027 |
Up |
| ECT2L |
NSC 688722 |
0.015 |
Down |
Expression pattern: Sensitivity / Resistance
Total:30 Current:18
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:24
Total:2 Current:1
[First] [Prev]  Next Last 
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|